Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells

Rheumatology

Volumn 47, Issue 4, 2008, Pages 418-424

  Nakamura, C ^a   Matsushita, I ^a   Kosaka, E ^a   Kondo, T ^a   Kimura, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Histone deacetylase inhibitor; Low intensity ultrasound; Rheumatoid; Sonoporation; Synovial fibroblasts

Indexed keywords

BETA ACTIN; CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 7; INTERSTITIAL COLLAGENASE; LIPOCORTIN 5; MACROPHAGE MIGRATION INHIBITION FACTOR; METHOTREXATE; PROPIDIUM IODIDE; SHU 508; STROMELYSIN; TRICHOSTATIN A; TRYPAN BLUE; TUMOR NECROSIS FACTOR; ENZYME INHIBITOR; HISTONE DEACETYLASE; HYDROXAMIC ACID; POLYSACCHARIDE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MICROBUBBLE; PHYSIOTHERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TOTAL KNEE REPLACEMENT; ULTRASOUND THERAPY; CELL CULTURE; CELL SURVIVAL; DNA MICROARRAY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE; GENETICS; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, CDC; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MICROBUBBLES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; ULTRASONIC THERAPY;

EID: 43049183658     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken003     Document Type: Article

References (37)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
2. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
3. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
4. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-80.
5. Chung YL, Lee MY, Wang AJ, Yao LF. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003;8:707-17.
6. Jungel A, Baresova V, Ospelt C et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. Ann Rheum Dis 2006;65:910-2.
7. Morinobu A, Wang B, Liu J, Yoshiya S, Kurosaka M, Kumagai S. Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts. J Rheumatol 2006;33:1052-60.
8. Nishida K, Komiyama T, Miyazawa S et al. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21WAF1/Cip1 expression. Arthritis Rheum 2004;50:3365-76.
9. Miller DL, Pislaru SV, Greenleaf JE. Sonoporation: Mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 2002;27:115-34.
10. Duvshani-Eshet M, Baruch L, Kesselman E, Shimoni E, Machluf M. Therapeutic ultrasound-mediated DNA to cell and nucleus: Bioeffects revealed by confocal and atomic force microscopy. Gene Ther 2006;13:163-72.
11. Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB, Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998;24:587-95.
12. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cellmembrane porosity by ultrasound. Lancet 1999;353:1409.
13. Chen S, Ding JH, Bekeredjian R et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 2006;103:8469-74.
14. Kondo I, Ohmori K, Oshita A et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J Am Coll Cardiol 2004;44:644-53.
15. Nakaya H, Shimizu T, Isobe K et al. Microbubble-enhanced ultrasound exposure promotes uptake of methotrexate into synovial cells and enhanced antiinflammatory effects in the knees of rabbits with antigen-induced arthritis. Arthritis Rheum 2005;52:2559-66.
16. Taniyama Y, Tachibana K, Hiraoka K et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: Enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-80.
17. Feril LB Jr, Kondo T, Cui ZG et al. Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett 2005;221:145-52.
18. Tabuchi Y, Ando H, Takasaki I et al. Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett 2007;246:149-56.
19. Ando H, Feril LB Jr, Kondo T et al. An echo-contrast agent, Levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells. Cancer Lett 2006;242:37-45.
20. Diakos C, Prieschl EE, Saemann M et al. Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate. J Biol Chem 2002;277:24243-51.
21. Huang N, Katz JP, Martin DR, Wu GD. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 1997;9:27-36.
22. Saemann MD, Parolini O, Bohmig GA et al. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J Leukoc Biol 2002;71:238-46.
23. Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 2001;276:44641-6.
24. Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 2003;111:539-52.
25. Ito K, Lim S, Caramori G et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99:8921-6.
26. Miao F, Gonzalo IG, Lanting L, Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004;279:18091-7.
27. Suuronen T, Huuskonen J, Pihlaja R, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem 2003;87:407-16.
28. Ryan QC, Headlee D, Acharya M et al. Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol 2005;23:3912-22.
29. Sandor V, Bakke S, Robey RW et al. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 2002;8:718-28.
30. Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996;22:1131-54.
31. Sowa Y, Orita T, Minamikawa S et al. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 1997;241:142-50.
32. Yoshida M, Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 1988;177:122-31.
33. KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol 2005;202:87-99.
34. Donadelli M, Costanzo C, Faggioli L et al. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 2003;38:59-69.
35. Noh EJ, Lee JS. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. Biochem Biophys Res Commun 2003;310:267-73.
36. Takai N, Desmond JC, Kumagai T et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin Cancer Res 2004;10:1141-9.
37. Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA 2004; 101:18030-5.